Alteration in the plasma concentration of a DAAO inhibitor, 3-methylpyrazole-5-carboxylic acid, in the ketamine-treated rats and the influence on the pharmacokinetics of plasma D-tryptophan

Proc Jpn Acad Ser B Phys Biol Sci. 2011;87(10):641-8. doi: 10.2183/pjab.87.641.

Abstract

A determination method for 3-methylpyrazole-5-carboxylic acid (MPC), an inhibitor of D-amino acid oxidase (DAAO), in rat plasma was developed by using high-performance liquid chromatography-mass spectrometry (LC-MS). The structural isomer of MPC, 3-methylpyrazole-4-carboxylic acid, was used as an internal standard, and the intra- and inter-day accuracies and precisions were satisfactory for the determination of plasma MPC.Next, the LC-MS method was applied to determine the plasma MPC concentration in ketamine (Ket)-treated rats after intraperitoneal administration of MPC (5.0 or 50 mg·kg(-1)). The C(max) value of plasma MPC concentration in the Ket-treated rats was significantly higher than that in the control group when a high dose of MPC (50 mg·kg(-1)) was administered. In addition, it was found that plasma D-tryptophan (D-Trp) concentration in Ket-treated rats administered D-Trp was not significantly increased by MPC, suggesting that the DAAO-inhibitory effect of MPC is attenuated in Ket-treated rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Chromatography, High Pressure Liquid
  • D-Amino-Acid Oxidase / antagonists & inhibitors*
  • Enzyme Inhibitors / blood*
  • Ketamine / pharmacology*
  • Male
  • Mass Spectrometry
  • Pyrazoles / blood*
  • Rats
  • Rats, Sprague-Dawley
  • Reproducibility of Results
  • Tryptophan / blood*

Substances

  • Enzyme Inhibitors
  • Pyrazoles
  • Ketamine
  • Tryptophan
  • D-Amino-Acid Oxidase
  • 5-methylpyrazole-3-carboxylic acid